Suppr超能文献

中心性浆液性脉络膜视网膜病变的病理生理学:文献回顾及质量评估。

Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

机构信息

Department of Ophthalmology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

University of Ottawa Eye Institute, The Ottawa Hospital, Ottawa, ON, Canada.

出版信息

Eye (Lond). 2022 May;36(5):941-962. doi: 10.1038/s41433-021-01808-3. Epub 2021 Oct 15.

Abstract

The pathogenesis of central serous chorioretinopathy (CSCR), a pachychoroid disease, is poorly understood. While choroid hyperpermeability and retinal pigment epithelium dysfunction are cornerstones for developing CSCR, the mechanisms at the retinal, vascular, retinal pigment epithelium, and cellular level continue to be an enigma. A few preclinical studies and the development of small-sized, poorly controlled clinical trials have resulted in limited insight into the disease mechanism. Effective treatments for CSCR are still lacking as current trials have produced inconsistent results for functional and structural gains. Thus, critically evaluating the literature to explore disease mechanisms and provide an up-to-date understanding of pathophysiology can provide valuable information and avenues to new treatments. In this study, a comprehensive summary of the mechanistic insight into CSCR is presented while highlighting the shortcomings of current literature. The mechanism was divided into seven sub-categories including mechanical obstruction, inflammation, oxidative stress, paracrine factors, autonomic dysfunction, mineralocorticoid receptors activation, and medications. We implemented validated tools like the JBI and CAMARADES to objectively analyze the quality of both clinical and preclinical studies, respectively. Overall, our analysis of the literature showed that no single mechanism was populated with a large number of sufficiently sized and good-quality studies. However, compiling these studies gave hints not only to CSCR pathogenesis but also pachychoroid disease in general while providing suggestions for future exploration.

摘要

中心性浆液性脉络膜视网膜病变(CSCR)是一种脉络膜增厚性疾病,其发病机制尚不清楚。脉络膜高通透性和视网膜色素上皮功能障碍是 CSCR 发生的基石,但视网膜、血管、视网膜色素上皮和细胞水平的机制仍不清楚。少数临床前研究和小型、控制不佳的临床试验的开展,使我们对疾病机制的认识仍然有限。由于目前的临床试验对功能和结构的改善效果不一致,CSCR 的有效治疗方法仍然缺乏。因此,批判性地评估文献以探索疾病机制并提供对病理生理学的最新理解,可以提供有价值的信息和新的治疗途径。在本研究中,我们对 CSCR 的机制研究进行了全面总结,同时强调了当前文献的不足之处。该机制分为七个亚类,包括机械阻塞、炎症、氧化应激、旁分泌因子、自主神经功能障碍、盐皮质激素受体激活和药物。我们分别使用经过验证的 JBI 和 CAMARADES 工具,客观地分析了临床和临床前研究的质量。总的来说,我们对文献的分析表明,没有任何一个单一的机制有大量足够大和高质量的研究支持。然而,这些研究的综合分析不仅为 CSCR 的发病机制提供了线索,也为脉络膜增厚性疾病提供了线索,并为未来的探索提供了建议。

相似文献

1
Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.
Eye (Lond). 2022 May;36(5):941-962. doi: 10.1038/s41433-021-01808-3. Epub 2021 Oct 15.
3
Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy.
Semin Ophthalmol. 2017;32(1):36-42. doi: 10.1080/08820538.2016.1228418. Epub 2016 Dec 8.
4
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.
Prog Retin Eye Res. 2015 Sep;48:82-118. doi: 10.1016/j.preteyeres.2015.05.003. Epub 2015 May 27.
5
Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Int Ophthalmol. 2017 Apr;37(2):409-416. doi: 10.1007/s10792-016-0278-4. Epub 2016 Jun 20.
6
7
Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies.
Eye Vis (Lond). 2023 Jul 11;10(1):33. doi: 10.1186/s40662-023-00349-y.
8
Pathomechanisms in central serous chorioretinopathy: A recent update.
Int J Retina Vitreous. 2023 Jan 20;9(1):3. doi: 10.1186/s40942-023-00443-2.
9
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.
Prog Retin Eye Res. 2020 Nov;79:100865. doi: 10.1016/j.preteyeres.2020.100865. Epub 2020 May 11.

引用本文的文献

1
A Comparative Study on the Prevalence of Infection in Patients with Central Serous Chorioretinopathy versus a Control Population.
Clin Ophthalmol. 2025 Jul 1;19:2067-2077. doi: 10.2147/OPTH.S519759. eCollection 2025.
2
Delayed Onset of Central Serous Chorioretinopathy following Corticosteroid Treatment for Giant Cell Arteritis: A Case Report.
Case Rep Ophthalmol. 2025 Apr 23;16(1):372-376. doi: 10.1159/000546053. eCollection 2025 Jan-Dec.
5
Unilateral Acute Serous Retinal Detachment with Pachychoroid Following Postpartum Haemorrhage: A Case Report.
Klin Monbl Augenheilkd. 2025 Apr;242(4):413-417. doi: 10.1055/a-2542-5369. Epub 2025 Apr 16.
8
Risk Factors and VEGF, hs-CRP, and ESR in Central Serous Chorioretinopathy.
J Ophthalmol. 2024 Sep 19;2024:9322594. doi: 10.1155/2024/9322594. eCollection 2024.
9
Increased oxidative stress biomarkers in central serous chorioretinopathy.
Sci Rep. 2024 Sep 10;14(1):21099. doi: 10.1038/s41598-024-71890-6.
10
The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects.
Front Pharmacol. 2024 May 21;15:1200492. doi: 10.3389/fphar.2024.1200492. eCollection 2024.

本文引用的文献

2
Central Serous Chorioretinopathy and Blood Serotonin Concentrations.
J Clin Med. 2021 Feb 3;10(4):558. doi: 10.3390/jcm10040558.
4
Choroidal congestion mouse model: Could it serve as a pachychoroid model?
PLoS One. 2021 Jan 28;16(1):e0246115. doi: 10.1371/journal.pone.0246115. eCollection 2021.
5
Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy.
Sci Rep. 2020 Nov 19;10(1):20175. doi: 10.1038/s41598-020-77202-y.
6
Focal choroidal excavation: review of literature.
Br J Ophthalmol. 2021 Aug;105(8):1043-1048. doi: 10.1136/bjophthalmol-2020-316992. Epub 2020 Aug 11.
7
Scleral Thickness in Central Serous Chorioretinopathy.
Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16.
8
Pachychoroid disease: a new perspective on exudative maculopathy.
Jpn J Ophthalmol. 2020 Jul;64(4):323-337. doi: 10.1007/s10384-020-00740-5. Epub 2020 Apr 21.
10
Systemic oxidative stress level in patients with central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1575-1577. doi: 10.1007/s00417-020-04664-1. Epub 2020 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验